These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8055463)

  • 41. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
    Dora SK; Dandapat AB; Pande B; Hota JP
    J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology.
    Van Holsbeke C; Van Belle V; Leone FP; Guerriero S; Paladini D; Melis GB; Greggi S; Fischerova D; De Jonge E; Neven P; Bourne T; Valentin L; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2010 Jul; 36(1):81-7. PubMed ID: 20217895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploratory Analysis of CA125-MGL and -STn Glycoforms in the Differential Diagnostics of Pelvic Masses.
    Salminen L; Nadeem N; Rolfsen AL; Dørum A; Laajala TD; Grènman S; Hietanen S; Heinosalo T; Perheentupa A; Poutanen M; Bolstad N; Carpén O; Lamminmäki U; Pettersson K; Gidwani K; Hynninen J; Huhtinen K
    J Appl Lab Med; 2020 Mar; 5(2):263-272. PubMed ID: 32445385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses?
    Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):215-25. PubMed ID: 17201017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of pulsed color Doppler in the presurgical evaluation of pelvic masses].
    Salle B; Gaucherand P; Ecochard R; Rudigoz RC
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):234-40. PubMed ID: 7622769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses.
    Fawzy A; Mohamed MR; Ali MA; Abd El-Magied MH; Helal AM
    Asian Pac J Cancer Prev; 2016; 17(1):323-33. PubMed ID: 26838232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.
    Zhang Z; Barnhill SD; Zhang H; Xu F; Yu Y; Jacobs I; Woolas RP; Berchuck A; Madyastha KR; Bast RC
    Gynecol Oncol; 1999 Apr; 73(1):56-61. PubMed ID: 10094881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of three risk of malignancy indices in evaluation of pelvic masses.
    Manjunath AP; Pratapkumar ; Sujatha K; Vani R
    Gynecol Oncol; 2001 May; 81(2):225-9. PubMed ID: 11330953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses.
    Finkler NJ; Benacerraf B; Lavin PT; Wojciechowski C; Knapp RC
    Obstet Gynecol; 1988 Oct; 72(4):659-64. PubMed ID: 3047614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation.
    Valentin L; Hagen B; Tingulstad S; Eik-Nes S
    Ultrasound Obstet Gynecol; 2001 Oct; 18(4):357-65. PubMed ID: 11778996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ascites as a predictor of ovarian malignancy.
    Shen-Gunther J; Mannel RS
    Gynecol Oncol; 2002 Oct; 87(1):77-83. PubMed ID: 12468346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound.
    Arun-Muthuvel V; Jaya V
    Asian Pac J Cancer Prev; 2014; 15(6):2929-32. PubMed ID: 24761927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
    Hogdall EV; Høgdall CK; Tingulstad S; Hagen B; Nustad K; Xu FJ; Bast RC; Jacobs IJ
    Int J Cancer; 2000 Nov; 89(6):519-23. PubMed ID: 11102897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer.
    Hata K; Hata T; Manabe A; Sugimura K; Kitao M
    Obstet Gynecol; 1992 Dec; 80(6):922-6. PubMed ID: 1448260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS).
    Rossi A; Braghin C; Soldano F; Isola M; Capodicasa V; Londero AP; Forzano L; Marchesoni D
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):84-8. PubMed ID: 21440361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
    Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
    Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis and Management of Adnexal Masses.
    Biggs WS; Marks ST
    Am Fam Physician; 2016 Apr; 93(8):676-81. PubMed ID: 27175840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
    Soper JT; Hunter VJ; Daly L; Tanner M; Creasman WT; Bast RC
    Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carcinoembryonic antigen in women with isolated pelvic masses. Clinical utility?
    Roman LD; Muderspach LI; Burnett AF; Morrow CP
    J Reprod Med; 1998 May; 43(5):403-7. PubMed ID: 9610461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.